Kathleen’s practice focuses on the defense of clients in all aspects of litigation, up to and including trial. To that end, Kat has served as trial counsel in cases involving pharmaceutical as well as consumer products.
Kat’s background as a clinical pharmacist in a major teaching hospital allowed her to develop an in-depth knowledge of a wide variety of pharmaceuticals and medical devices, experience that provides a valuable foundation for her Life Sciences and Biotechnology practice.
In addition to her role as trial counsel, Kat has wide-ranging and extensive experience in all aspects of pretrial case workup, including fact and expert discovery, both in individual cases and in the mass tort setting.
Kat also has substantial experience in company witness development and preparation. She has had top-level coordination and management roles in nationwide litigation and regularly provides global litigation strategy consultation to pharmaceutical, medical device and consumer product manufacturers. Kat has defended manufacturers in numerous federal multidistrict litigations (MDLs), including those involving thimerosal, diet drugs, hormone therapy, hormone patches, contact lens solution, contrast agents, psychotropic medications, antibiotic medications, hip implants, mesh implants, cardiac defibrillators and consumer products.
Mark Behrens & Kathleen Frazier, Multi-District Litigation Updates, FDCC Corporate Counsel Symposium, October 22, 2023.
Gene M. Williams & Kathleen Frazier, Drug Manufacturers’ Defenses: Everything Old is New Again, 25:4 WLF Legal Backgrounder, Jan. 29, 2010.